Neurotechnology developers work at the intersection of neuroscience and engineering, creating innovative tools that enhance our understanding of the brain and improve treatments for neurological conditions. They design and implement technologies such as brain-computer interfaces (BCIs), neural prosthetics, and neuroimaging devices to monitor, diagnose, and treat neurological disorders. These specialists collaborate with neuroscientists, clinicians, and biomedical engineers to develop devices that can interface directly with the brain, providing patients with the ability to control prosthetic limbs or communicate through thought. Neurotechnology developers are also involved in the creation of advanced neuroimaging systems, which allow for detailed, real-time observation of brain activity in patients with conditions like epilepsy or Parkinson’s disease. Their work extends to innovations in neural stimulation therapies, such as transcranial magnetic stimulation (TMS), which is used to treat mood disorders, pain, and neurological rehabilitation. With rapid advancements in artificial intelligence and machine learning, neurotechnology developers are increasingly leveraging these technologies to improve diagnostics, optimize treatment protocols, and provide personalized care. They play a pivotal role in advancing the field of neuroengineering, with the goal of improving the quality of life for individuals with neurological disorders through cutting-edge technologies.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States